Children's Hospital Los Angeles
256
55
77
121
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.2%
26 terminated/withdrawn out of 256 trials
82.3%
-4.2% vs industry average
7%
19 trials in Phase 3/4
45%
55 of 121 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (256)
Designing Team Clinic for Youth With Type 2 Diabetes
Role: lead
Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease
Role: lead
Cool Prime Comparative Effectiveness Study for Mild HIE
Role: collaborator
Device Use Reimagined Through Education And Mentorship
Role: collaborator
Bridge the Gap (BTG) - Black Youth Group
Role: lead
Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
Role: lead
Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings
Role: lead
Retinoblastoma Patient Clinical Database and Tissue Repository
Role: lead
Maralixibat in Patients With Cystic Fibrosis and Constipation
Role: lead
Virtual ACT for Adolescent Stress
Role: lead
Clinical Decision Support Tool in PARDS Pilot Study
Role: lead
Crisis Interventions for Pediatric Providers - Autism Version
Role: lead
Digital Self-Management and Peer Mentoring Intervention
Role: collaborator
Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis
Role: collaborator
Feasibility of the Reality PAWS Program for Children in Isolation
Role: collaborator
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW
Role: collaborator
Exercise in Child Health
Role: collaborator
Neuroblastoma Precision Trial
Role: collaborator
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Role: collaborator
Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth
Role: lead